Huge congrats on redefining rejection and changing the status quo Jeremy Kobulnik Jeff Teuteberg Kiran Khush

Fantastic experience being a faculty member with the incredible Nir Uriel, MD MSc and Albert Hicks MD, MPH at the Abbott Cardiovascular Advanced MCS Topics course in NYC 🫀👩‍⚕️🌆

I always learn so much and am so inspired by my colleagues across the country!

Phenomenal set of discussions/ from experts Nir Uriel, MD MSc Albert Hicks MD, MPH Amy Fiedler, MD at the MCS Advanced Topics program Abbott. Survival on LVAD better than ever. Many strategies to further improve survival and QoL. Address HRAEs and enhance multidisciplinary collaboration.

My first Rutgers Day! A pleasure to represent RWJ Barnabas Health showcasing our advanced HF service line at New Brunswick. Demonstrating HMIII LVAD here. My family loved it too! Partho P Sengupta RWJBarnabas Rutgers University

Diagnosis and Management of Cardiac Sarcoidosis #AHAJournals
ahajournals.org/doi/10.1161/CI…

🔑 ACC/AHA/HFSA recommends continuation of HFrEF GDMT despite improvement in LVEF & ESC does not have formal recommendations

Read key points from a review comparing clinical practice recommendations for #heartfailure in the American & European guidelines: bit.ly/444zSJP

ISHLT endorses the 7th World Symposium on Pulmonary Hypertension that will be held 29 June - 1 July in Barcelona. The purpose of #WSPH2024 is to foster constructive scientific interactions and collaborations in the field of #PH . Learn more at 🔗 bit.ly/3J7w9BW

Prediction of RV failure after LVAD placement - so many parameters to consider, little consensus! #ISHLT2024

Song Li presented a cool study examining MCS use patterns in #CSWG registry: more consistent MCS choices in sicker pts, but lots of variations remain ➡️ need more data on right device for right patient! #ISHLT2024

Percutaneous intervention of a HeartMate 3 extrinsic outflow graft obstruction using large covered stents UChicago Medicine University of Chicago Cardiology Fellowship AbdulRahman A Abutaleb
Sara Kalantari MD Jon Grinstein MD @AtmanShah

sciencedirect.com/science/articl…

Thanks to The ISHLT for inviting me to share our work on CAV waitlist mortality.

🚨 Spoiler alert 🚨

It’s bad.

CAV at Status 4 should be Status 3
CAV at Status 3 should be Status 2

#ISHLT2024 #transplant

Andrew J Sauer MD While I agree, it will be nice to have randomized data. Study led by #CSWG

Pressure-volume loops uncover occult RV dysfunction & ↓ reserve in LVAD, w/ PAPi as potential surrogate; ↓septal contraction 2/2 LV unloading a possible mechanism based on echo septal strain Paul Scheel, Steve Hsu, Johns Hopkins Cardiology

🔗 jhltonline.org/article/S1053-…

So proud. Dr Chony Alberts doing great. Moderating major LVAD session at ISHLT. ⁦Cleveland Clinic Heart, Vascular & Thoracic⁩ ; ⁦Samir Kapadia⁩;

#ISHLT2024

Can we identify advanced HF patients with high likelihood for heart recovery before they commit to advanced therapies pathway (Tx, VAD, other) ?

“Yes, we can” !
Multi-center cardiac recovery personalized calculator
Derivation: 5 sites
External Validation: 4 sites